CAS: 1346242-81-6 - N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine
Formula:C25H30N6O2
InChI:InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
InChI key:InChIKey=OLAHOMJCDNXHFI-UHFFFAOYSA-N
SMILES:N1=CC(=NC=2C=C(C=CC12)N(C=3C=C(OC)C=C(OC)C3)CCNC(C)C)C=4C=NN(C4)C
- Synonyms:
- JNJ-42756493
- 1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-
- N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine
- Suftalan Zine
- JNJ 42756493
- Balversa
- N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
- N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine
- Erdafitinib
Ref: 4Z-E-236001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 4Z-K-034004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Erdafitinib
CAS:1346242-81-6
Erdafitinib (JNJ-42756493) is a quinoxaline derivative compound, acts on FGFR1/2/3/4.
Formula:
C25H30N6O2
Purity:
97% - 99.07%
Color and Shape:
Solid
Molecular weight:
446.54
Ref: TM-T3726
5mg | 46.00 € | ||
10mg | 69.00 € | ||
25mg | 94.00 € | ||
50mg | 149.00 € | ||
100mg | 221.00 € | ||
500mg | 558.00 € | ||
1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-E-236004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Erdafitinib
CAS:1346242-81-6
Fibroblast growth factor receptor inhibitor
Formula:
C25H30N6O2
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
446.54 g/mol
Ref: 3D-FE76167
10mg | 168.00 € | ||
50mg | 345.00 € | ||
100mg | 488.00 € | ||
250mg | 723.00 € | ||
500mg | 1,055.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Erdafitinib
Controlled ProductCAS:1346242-81-6
Applications Erdafitinib is a fibroblast growth factor receptor inhibitor. References Perera, T. P. S., et …
Formula:
C25H30N6O2
Color and Shape:
Neat
Molecular weight:
446.54
Ref: TR-E594600
1mg | 85.00 € | ||
10mg | 223.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Ref: 4Z-K-031041
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |